A detailed history of Sandy Spring Bank transactions in Novo Nordisk A S stock. As of the latest transaction made, Sandy Spring Bank holds 2,996 shares of NVO stock, worth $410,452. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,996
Previous 2,942 1.84%
Holding current value
$410,452
Previous $377,000 13.26%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $6,626 - $7,933
54 Added 1.84%
2,996 $427,000
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $29,816 - $39,688
292 Added 11.02%
2,942 $377,000
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $111,856 - $245,434
1,230 Added 86.62%
2,650 $240,000
Q2 2023

Aug 04, 2023

SELL
$155.98 - $172.65 $1,091 - $1,208
-7 Reduced 0.49%
1,420 $229,000
Q1 2023

May 05, 2023

BUY
$132.34 - $159.14 $36,658 - $44,081
277 Added 24.09%
1,427 $227,000
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $102,550 - $135,330
1,000 Added 666.67%
1,150 $155,000
Q3 2022

Nov 02, 2022

SELL
$95.28 - $116.93 $4,764 - $5,846
-50 Reduced 25.0%
150 $15,000
Q1 2022

May 03, 2022

SELL
$93.1 - $112.54 $9,310 - $11,254
-100 Reduced 33.33%
200 $22,000
Q2 2021

Aug 09, 2021

SELL
$67.66 - $84.76 $6,766 - $8,476
-100 Reduced 25.0%
300 $25,000
Q1 2021

May 03, 2021

SELL
$67.06 - $75.82 $6,706 - $7,581
-100 Reduced 20.0%
400 $27,000
Q2 2020

Aug 12, 2020

SELL
$58.54 - $67.94 $2,283 - $2,649
-39 Reduced 7.24%
500 $33,000
Q1 2020

May 01, 2020

SELL
$49.46 - $64.78 $7,963 - $10,429
-161 Reduced 23.0%
539 $32,000
Q1 2019

May 06, 2019

SELL
$46.36 - $52.63 $24,617 - $27,946
-531 Reduced 43.14%
700 $37,000
Q3 2018

Nov 07, 2018

BUY
$46.76 - $51.24 $11,923 - $13,066
255 Added 26.13%
1,231 $58,000
Q4 2017

Feb 02, 2018

BUY
$47.53 - $53.73 $46,389 - $52,440
976 New
976 $52,000
Q3 2017

Nov 03, 2017

SELL
$41.15 - $49.22 $5,966 - $7,136
-145 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
145
145 $6,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $309B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.